RxDoctor Payments Data

Kerry Cox, PA

Physician Assistant · Roy, UTNPI 1992477632

Payments from drug & device makers

$5,666in general payments, 2019–2025

Across 319 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$846
  • Lilly USA, LLC$414
  • Amgen$399
  • GSK$368
  • Novo Nordisk$326
  • Pfizer$325
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$5,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,666 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$29,570
Medicare patients
121
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide71$86,634
JardianceEmpagliflozin55$68,978
OzempicSemaglutide46$51,860
EliquisApixaban27$31,064
MyrbetriqMirabegron33$25,388
FarxigaDapagliflozin Propanediol17$18,046
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$16,265
Synjardy XrEmpagliflozin/Metformin Hcl13$16,129
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,215
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,834
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$5,964
Tresiba Flextouch U-100Insulin Degludec14$5,507
Semglee (Yfgn) PenInsulin Glargine-Yfgn11$4,107
Omeprazole114$2,133
Gabapentin98$1,622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$414$86,63471 claims
Boehringer IngelheimJardiance, Synjardy Xr$233$85,10768 claims
Novo NordiskOzempic$326$51,86046 claims
PfizerEliquis$325$31,06427 claims
AstraZenecaFarxiga, Breztri Aerosphere$322$29,26135 claims
Astellas Pharma US IncMyrbetriq$265$25,38833 claims
GSKTrelegy Ellipta$368$10,83412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Roy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →